{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:50:11Z","timestamp":1762206611486,"version":"build-2065373602"},"reference-count":57,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005963","name":"LAM Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 CA100907"],"award-info":[{"award-number":["RO1 CA100907"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001771","name":"Tuberous Sclerosis Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jid.2021.02.754","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T18:00:50Z","timestamp":1616781650000},"page":"2291-2299.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-Term Effects of Sirolimus on Human Skin TSC2-Null Fibroblast\u2012Like Cells"],"prefix":"10.1016","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4644-4451","authenticated-orcid":false,"given":"Xiong","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4749-4418","authenticated-orcid":false,"given":"Qingyuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3388-7595","authenticated-orcid":false,"given":"Gi Soo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3326-3662","authenticated-orcid":false,"given":"Kelsey","family":"Grolig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4828-3268","authenticated-orcid":false,"given":"Xiaoyan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4062-071X","authenticated-orcid":false,"given":"Eric M.","family":"Billings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2793-7122","authenticated-orcid":false,"given":"Gustavo","family":"Pacheco-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5161-1974","authenticated-orcid":false,"given":"Thomas N.","family":"Darling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1788-1927","authenticated-orcid":false,"given":"Joel","family":"Moss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2021.02.754_bib1","first-page":"2795","article-title":"An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas","volume":"8","author":"Allen","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jid.2021.02.754_bib2","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.2353\/ajpath.2010.090233","article-title":"Tuberin regulates E-cadherin localization: implications in epithelial-mesenchymal transition","volume":"177","author":"Barnes","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2021.02.754_bib3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2021.02.754_bib4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/377441a0","article-title":"Control of p70 s6 kinase by kinase activity of FRAP in\u00a0vivo","volume":"377","author":"Brown","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.jid.2021.02.754_bib5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1053\/j.ajkd.2011.10.013","article-title":"Tuberous sclerosis complex-associated angiomyolipomas: focus on mTOR inhibition","volume":"59","author":"Budde","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jid.2021.02.754_bib6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/mc.20628","article-title":"Rapamycin regulates Akt and ERK phosphorylation through mTORC1 and mTORC2 signaling pathways","volume":"49","author":"Chen","year":"2010","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.jid.2021.02.754_bib7","first-page":"3147","article-title":"The story of MCF-7 breast cancer cell line: 40 years of experience in research","volume":"35","author":"Com\u015fa","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jid.2021.02.754_bib8","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jamadermatol.2018.0465","article-title":"Topical sirolimus to treat tuberous sclerosis complex (TSC)","volume":"154","author":"Darling","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2021.02.754_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/lrb.2009.0031","article-title":"Lymphangioleiomyomatosis and TSC2-\/- cells","volume":"8","author":"Darling","year":"2010","journal-title":"Lymphat Res Biol"},{"key":"10.1016\/j.jid.2021.02.754_bib10","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.chest.2017.01.033","article-title":"Sirolimus and autophagy inhibition in lymphangioleiomyomatosis: results of a Phase I clinical trial","volume":"151","author":"El-Chemaly","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.jid.2021.02.754_bib11","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1158\/0008-5472.CAN-04-3840","article-title":"Estrogen enhances whereas tamoxifen retards development of Tsc mouse liver hemangioma: a tumor related to renal angiomyolipoma and pulmonary lymphangioleiomyomatosis","volume":"65","author":"El-Hashemite","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2021.02.754_bib12","doi-asserted-by":"crossref","first-page":"23114","DOI":"10.1074\/jbc.M401912200","article-title":"Estrogen-induced smooth muscle cell growth is regulated by tuberin and associated with altered activation of platelet-derived growth factor receptor-beta and ERK-1\/2","volume":"279","author":"Finlay","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2021.02.754_bib13","doi-asserted-by":"crossref","first-page":"30958","DOI":"10.1074\/jbc.M202678200","article-title":"Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM)","volume":"277","author":"Goncharova","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2021.02.754_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2045-824X-4-11","article-title":"Cooperative benefit for the combination of rapamycin and imatinib in tuberous sclerosis complex neoplasia","volume":"4","author":"Govindarajan","year":"2012","journal-title":"Vasc Cell"},{"key":"10.1016\/j.jid.2021.02.754_bib15","first-page":"149","article-title":"Human cultured skin fibroblasts express estrogen receptor alpha and beta","volume":"10","author":"Haczynski","year":"2002","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jid.2021.02.754_bib16","first-page":"903","article-title":"Differential effects of estradiol, raloxifene and tamoxifen on estrogen receptor expression in cultured human skin fibroblasts","volume":"13","author":"Haczynski","year":"2004","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jid.2021.02.754_bib17","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jid.2021.02.754_bib18","doi-asserted-by":"crossref","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous sclerosis complex","volume":"2","author":"Henske","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jid.2021.02.754_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSC1-TSC2 complex: a molecular switchboard controlling cell growth","volume":"412","author":"Huang","year":"2008","journal-title":"Biochem J"},{"key":"10.1016\/j.jid.2021.02.754_bib20","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.molonc.2014.11.005","article-title":"Endoplasmic reticulum stress and cell death in mTORC1-overactive cells is induced by nelfinavir and enhanced by chloroquine","volume":"9","author":"Johnson","year":"2015","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jid.2021.02.754_bib21","first-page":"4355","article-title":"Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens","volume":"47","author":"Katzenellenbogen","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2021.02.754_bib22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.trecan.2016.11.006","article-title":"The strange case of CDK4\/6 inhibitors: mechanisms, resistance, and combination strategies","volume":"3","author":"Knudsen","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jid.2021.02.754_bib23","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jamadermatol.2018.0464","article-title":"Efficacy and safety of topical rapamycin in patients with facial angiofibromas secondary to tuberous sclerosis complex: the TREATMENT randomized clinical trial","volume":"154","author":"Koenig","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2021.02.754_bib24","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1124\/jpet.105.083550","article-title":"LY303511 (2-piperazinyl-8-phenyl-4H-1-benzopyran-4-one) acts via phosphatidylinositol 3-kinase-independent pathways to inhibit cell proliferation via mammalian target of rapamycin (mTOR)- and non-mTOR-dependent mechanisms","volume":"314","author":"Kristof","year":"2005","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jid.2021.02.754_bib25","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2021.02.754_bib26","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1242\/jcs.051011","article-title":"mTOR signaling at a glance","volume":"122","author":"Laplante","year":"2009","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.jid.2021.02.754_bib27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jid.2021.02.754_bib28","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1073\/pnas.0712397105","article-title":"Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas","volume":"105","author":"Li","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2021.02.754_bib29","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1084\/jem.20042469","article-title":"MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development","volume":"202","author":"Li","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2021.02.754_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ncomms1236","article-title":"Human TSC2-null fibroblast-like cells induce hair follicle neogenesis and hamartoma morphogenesis","volume":"2","author":"Li","year":"2011","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2021.02.754_bib31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","article-title":"mTOR at the nexus of nutrition, growth, ageing and disease","volume":"21","author":"Liu","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jid.2021.02.754_bib32","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.08.053","article-title":"The regulation of cell size","volume":"154","author":"Lloyd","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jid.2021.02.754_bib33","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jaad.2017.04.005","article-title":"Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: a prospective study of 25 patients","volume":"77","author":"Malissen","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2021.02.754_bib34","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jid.2021.02.754_bib35","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2021.02.754_bib36","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cell.2013.11.049","article-title":"Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome","volume":"156","author":"Menon","year":"2014","journal-title":"Cell"},{"issue":"Suppl. 1","key":"10.1016\/j.jid.2021.02.754_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaad.2004.05.044","article-title":"Rapamycin (sirolimus) as a steroid-sparing agent in dermatomyositis","volume":"52","author":"Nadiminti","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2021.02.754_bib38","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jaad.2015.07.018","article-title":"Improvement of tuberous sclerosis complex (TSC) skin tumors during long-term treatment with oral sirolimus","volume":"73","author":"Nathan","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2021.02.754_bib39","doi-asserted-by":"crossref","first-page":"12455","DOI":"10.1073\/pnas.1104361108","article-title":"Tumorigenesis in tuberous sclerosis complex is autophagy and p62\/sequestosome 1 (SQSTM1)-dependent","volume":"108","author":"Parkhitko","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2021.02.754_bib40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0092-8674(01)00333-6","article-title":"Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size","volume":"105","author":"Potter","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.jid.2021.02.754_bib41","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1093\/hmg\/ddp271","article-title":"Functional interaction of mammalian target of rapamycin complexes in regulating mammalian cell size and cell cycle","volume":"18","author":"Rosner","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jid.2021.02.754_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol Cell"},{"key":"10.1016\/j.jid.2021.02.754_bib43","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jid.2021.02.754_bib44","doi-asserted-by":"crossref","first-page":"24361","DOI":"10.18632\/oncotarget.4458","article-title":"eIF3 controls cell size independently of S6K1-activity","volume":"6","author":"Schipany","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2021.02.754_bib45","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","article-title":"CDK inhibitors: positive and negative regulators of G1-phase progression","volume":"13","author":"Sherr","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.jid.2021.02.754_bib46","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1158\/0008-5472.CAN-05-0917","article-title":"Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition","volume":"65","author":"Sun","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2021.02.754_bib47","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-154-12-201106210-00007","article-title":"Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus","volume":"154","author":"Taveira-DaSilva","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jid.2021.02.754_bib48","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/CLEP.S50780","article-title":"Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis","volume":"7","author":"Taveira-DaSilva","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jid.2021.02.754_bib49","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/jamadermatol.2014.938","article-title":"Dermatologic and dental aspects of the 2012 International Tuberous Sclerosis Complex Consensus Statements","volume":"150","author":"Teng","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2021.02.754_bib50","doi-asserted-by":"crossref","first-page":"e60014","DOI":"10.1371\/journal.pone.0060014","article-title":"MicroRNA-21 is induced by rapamycin in a model of tuberous sclerosis (TSC) and lymphangioleiomyomatosis (LAM)","volume":"8","author":"Trindade","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2021.02.754_bib51","doi-asserted-by":"crossref","first-page":"R368","DOI":"10.1016\/j.cub.2012.03.003","article-title":"Organ size control by Hippo and TOR pathways","volume":"22","author":"Tumaneng","year":"2012","journal-title":"Curr Biol"},{"key":"10.1016\/j.jid.2021.02.754_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005637","article-title":"Mosaic and intronic mutations in TSC1\/TSC2 explain the majority of TSC patients with no mutation identified by conventional testing","volume":"11","author":"Tyburczy","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jid.2021.02.754_bib53","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/sj.onc.1209990","article-title":"Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism","volume":"26","author":"Wan","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2021.02.754_bib54","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jamadermatol.2016.3545","article-title":"Efficacy and safety of topical sirolimus therapy for facial angiofibromas in the tuberous sclerosis complex : a randomized clinical trial","volume":"153","author":"Wataya-Kaneda","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2021.02.754_bib55","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jamadermatol.2014.4298","article-title":"Clinical and histologic analysis of the efficacy of topical rapamycin therapy against hypomelanotic macules in tuberous sclerosis complex","volume":"151","author":"Wataya-Kaneda","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2021.02.754_bib56","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.4161\/auto.7.11.17652","article-title":"Autophagy: an 'Achilles' heel of tumorigenesis in TSC and LAM","volume":"7","author":"Yu","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.jid.2021.02.754_bib57","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1073\/pnas.0810790106","article-title":"Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells","volume":"106","author":"Yu","year":"2009","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X21011209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X21011209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:47:26Z","timestamp":1762206446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X21011209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":57,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0022202X21011209"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2021.02.754","relation":{},"ISSN":["0022-202X"],"issn-type":[{"type":"print","value":"0022-202X"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Effects of Sirolimus on Human Skin TSC2-Null Fibroblast\u2012Like Cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2021.02.754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}